Discover
ANAB
AnaptysBio, Inc.
45.95
2 x 33.85
2 x 59.16
bid
ask
-
0.26
0.56%
2 @ 07:44 PM
45.76 -0.19 (0.41%)
| Ytd | 42.17% | |
| 1y | 116.95% |
45.81
day range
47.19
20.91
52 week range
69.81
| Open | 46.11 | Prev Close | 46.21 | Low | 45.81 | High | 47.19 | Mkt Cap | 1.37B |
| Vol | 495.67K | Avg Vol | 565.82K | EPS | -0.96 | P/E | N/A | Forward P/E | 9.07 |
| Beta | 0.45 | Short Ratio | 12.32 | Inst. Own | 105.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 54.52 | 200-d Avg | 49.12 | 1yr Est | 87.25 |
ANAB News
benzinga.com
JP Morgan Maintains Overweight on AnaptysBio, Lowers Price Target to $60
JP Morgan analyst Anupam Rama maintains AnaptysBio (NASDAQ:ANAB) with a Overweight and lowers the
benzinga.com
HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $95 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates AnaptysBio (NASDAQ:ANAB) with a Buy a
benzinga.com
Leerink Partners Maintains Outperform on AnaptysBio, Lowers Price Target to $81
Leerink Partners analyst David Risinger maintains AnaptysBio (NASDAQ:ANAB) with a Outperform and
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's
benzinga.com
AnaptysBio Q2 Adj. EPS $(0.11) Beats $(0.46) Estimate, Sales $27.488M Beat $21.675M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(0.11) per share which beat the analyst conse